BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Gero

Gero logo

Founded
2012
Geography
Singapore based
Funding
$2.200 M

Gero is an AI-powered platform for drug discovery and drug repurposing focused on complex diseases and aging.


aging longevity bioarker identification mHealth

Technologies

AI Companies (Drug Discovery)   Aging Research  

R&D Platform

GERO.AI identifies rare mutations that sufficiently affect human health from real-world big clinical and genetic (WES) and molecular data and then suggests druggable targets and drugs (mimicking or inhibiting) the effect of the mutation treat the disease. We can aggregate the effects of multiple rare mutations on the level of biological processes (or pathways) and give you numerous choices of interventions with the required effect.


GeroSense
mobile app

Read more

Pipelines

None
Preclinical  |  Visit website

None

Products

 

Services

No services posted yet